4,388
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD)

, , , , , , & show all
Pages 152-159 | Received 08 Feb 2019, Accepted 11 Apr 2019, Published online: 23 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Paola Rogliani, Beatrice Ludovica Ritondo, Mariachiara Gabriele, Mario Cazzola & Luigino Calzetta. (2020) Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings. Expert Review of Clinical Pharmacology 13:9, pages 977-990.
Read now

Articles from other publishers (14)

Jennifer K. Quint, Amnon Ariel & Peter J. Barnes. (2023) Rational use of inhaled corticosteroids for the treatment of COPD. npj Primary Care Respiratory Medicine 33:1.
Crossref
Smit Patel, Scott Dickinson, Kevin Morris, Helen F. Ashdown & James D. Chalmers. (2022) A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients. npj Primary Care Respiratory Medicine 32:1.
Crossref
浩 杨. (2022) Research Progress on Discontinuation of ICS with Triple Inhaled Drugs for Chronic Obstructive Pulmonary Disease. Advances in Clinical Medicine 12:07, pages 6963-6974.
Crossref
Meropi Karakioulaki & Daiana Stolz. 2022. Eosinophilic Lung Diseases. Eosinophilic Lung Diseases 100 118 .
Hanna Sandelowsky, Ulla Møller Weinreich, Bernt B. Aarli, Josefin Sundh, Kristian Høines, Georgios Stratelis, Anders Løkke, Christer Janson, Christian Jensen & Kjell Larsson. (2021) COPD – do the right thing. BMC Family Practice 22:1.
Crossref
Helgo Magnussen, Sarah Lucas, Therese Lapperre, Jennifer K. Quint, Ronald J. Dandurand, Nicolas Roche, Alberto Papi, David Price & Marc Miravitlles. (2021) Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study. Respiratory Research 22:1.
Crossref
Hsu-Hui Wang & Shih-Lung Cheng. (2021) From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease. Biomedicines 9:11, pages 1638.
Crossref
Li-Yen Lee, Geena Suet Yin Hew, Meenu Mehta, Shakti D. Shukla, Saurabh Satija, Navneet Khurana, Krishnan Anand, Harish Dureja, Sachin Kumar Singh, Vijay Mishra, Pankaj Kumar Singh, Monica Gulati, Parteek Prasher, Alaa A.A. Aljabali, Murtaza M. Tambuwala, Lakshmi Thangavelu, Jithendra Panneerselvam, Gaurav Gupta, Flavia C. Zacconi, Madhur Shastri, Niraj Kumar Jha, Dikaia Xenaki, Ronan MacLoughlin, Brian G. Oliver, Dinesh Kumar Chellappan & Kamal Dua. (2021) Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. Life Sciences 267, pages 118973.
Crossref
Mario Cazzola, Maria Gabriella Matera & Paola Rogliani. (2021) Blood Eosinophils in Chronic Obstructive Pulmonary Disease: Is There Enough Evidence?. US Respiratory & Pulmonary Diseases 6:1, pages 31.
Crossref
Timothy H. Harries, Victoria Rowland, Christopher J. Corrigan, Iain J. Marshall, Lucy McDonnell, Vibhore Prasad, Peter Schofield, David Armstrong & Patrick White. (2020) Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis. Respiratory Research 21:1.
Crossref
James D. Chalmers, Irena F. Laska, Frits M.E. Franssen, Wim Janssens, Ian Pavord, David Rigau, Melissa J. McDonnell, Nicolas Roche, Don D. Sin, Daiana Stolz, Samy Suissa, Jadwiga Wedzicha & Marc Miravitlles. (2020) Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline. European Respiratory Journal 55:6, pages 2000351.
Crossref
Daiana Stolz & Marc Miravitlles. (2020) The right treatment for the right patient with COPD: lessons from the IMPACT trial. European Respiratory Journal 55:5, pages 2000881.
Crossref
Taisuke Jo, Hideo Yasunaga, Yasuhiro Yamauchi, Akihisa Mitani, Yoshihisa Hiraishi, Wakae Hasegawa, Yukiyo Sakamoto, Hiroki Matsui, Kiyohide Fushimi & Takahide Nagase. (2020) Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study. ERJ Open Research 6:1, pages 00246-2019.
Crossref
Thomas Jones. (2019) Initial inhaler choice in COPD: real-world evidence. Breathe 15:4, pages 350-352.
Crossref